[Therapy of arterial occlusive diseases. The effect of bencyclan in trained patients with peripheral arterial occlusive disease (Double-blind study)].
D000328:Adult; D000368:Aged; D001157:Arterial Occlusive Diseases / Q000628:therapy*; D001537:Bencyclane / Q000009:adverse effects / Q000627:therapeutic use*; D003508:Cycloheptanes / Q000627:therapeutic use*; D004311:Double-Blind Method; D004341:Drug Evaluation; D006801:Humans; D007383:Intermittent Claudication / Q000188:drug therapy; D008875:Middle Aged; D009132:Muscles / Q000378:metabolism; D026741:Physical Therapy Modalities; D014978:Xenon / Q000378:metabolism
D003508:Cycloheptanes; D014978:Xenon; D001537:Bencyclane
Zur Therapie der arteriellen Verschlusskrankheit. Untersuchungen über die Wirksamkeit von Bencyclan bei trainierten Patienten mit peripherer arterieller Verschlusskrankheit (Doppelblind-Versuch).